Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 17, 2012

View Archived Issues

GSK develops new RAR-related orphan receptor-gamma modulators

Antigen Discovery's malaria research supported by new SBIR grant

Herbal extract mix efficacious in Alzheimer's disease model

Roche reports novel bradykinin B1 receptor antagonists

Boehringer Ingelheim Pharma patents new prostanoid DP2 receptor antagonists

New potential candidate cognition-enhancing drugs designed

Chinaberry fruit extract shows promise to treat Alzheimer's disease

Investigation yields novel candidate anticancer drugs

New candidate immunotherapies divulged by UCB

Novel complement activation-inhibiting products synthesized

Upsher-Smith Laboratories completes acquisition

Unigene and Nordic Bioscience select preliminary lead compound for type 2 diabetes

Novel silicon-containing compounds display antiallergic activity

Synergy Pharmaceuticals reaches enrollment target in plecanatide trial

Regulus Therapeutics forms microRNA alliance with AstraZeneca

Cortex Pharmaceuticals announces merger

Regulus and Biogen Idec establish biomarker collaboration

FDA clears phase I study of UMK-121

CRT licenses preclinical FAK inhibitor programs

Promising results reported for SNS01-T in multiple myeloma study

Safety monitoring board recommends continuation of PreSERVE-AMI trial

IND filed for APX-001

Lexicon Pharmaceuticals releases topline data on LX-2931 and LX-7101

Pluristem's PLX cells set to enter phase II study in India

FDA places partial clinical hold on Idenix program

Development collaboration begins for TGR-1202

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
HX-16108 holds promise for treating inflammatory skin diseases
BioWorld Science
Atopic dermatitis (AD) is an inflammatory skin disease accompanied by pruritus, for which IL-13 and IL-31 are clinically validated targets. Earendil Labs Inc. has...